New therapeutic targets for amyotrophic lateral sclerosis

Author： Kuzma-Kozakiewicz Magdalena   Kwiecinski Hubert  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.15, Iss.2, 2011-02, pp. : 127-143

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis

By Corona Juan C   Tovar-y-Romo Luis B   Tapia Ricardo  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 11, 2007-11 ,pp. : 1415-1428

Informa Healthcare

Access to resources Recommend Favorite

Molecular Insights and Therapeutic Targets in Amyotrophic Lateral Sclerosis

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 1, 2008-02 ,pp. : 11-19

Bentham Science Publishers

Access to resources Recommend Favorite

Diagnosis, Pathogenesis and Therapeutic Targets in Amyotrophic Lateral Sclerosis

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 6, 2010-12 ,pp. : 764-778

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Determinants of Amyotrophic Lateral Sclerosis as Therapeutic Targets

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 6, 2010-12 ,pp. : 779-790

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic advances in amyotrophic lateral sclerosis

By Louvel E.   Hugon J.   Doble A.  

Trends in Pharmacological Sciences, Vol. 18, Iss. 6, 1997-06 ,pp. : 196-203

Elsevier

Access to resources Recommend Favorite